(Q47105068)
Statements
A phase I/II study of KW-2478, an Hsp90 inhibitor, in combination with bortezomib in patients with relapsed/refractory multiple myeloma (English)
J Cavenagh
H Oakervee
P Baetiong-Caguioa
M Gharibo
N Rabin
M Kurman
B Novak
N Shiraishi
D Nakashima
S Akinaga